Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery?
Kort samengevat
Novo Nordisk A/S (NYSE:NVO) has entered a strategic partnership with Amazon Web Services to accelerate drug discovery and modernize its operations through artificial intelligence and cloud technology.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Insider Monkey.
Lees het volledige bericht ↗